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Objectives: To understand the concerns and
challenges faced by general practitioners (GPs) and
respiratory physicians about primary care management
of acute exacerbations in patients with chronic
obstructive pulmonary disease (COPD).
Design: 21 focus group discussions (FGDs) were
performed in seven countries with a Grounded Theory
approach. Each country performed three rounds of
FGDs.
Setting: Primary and secondary care in Norway,
Germany, Wales, Poland, Russia, The Netherlands,
China (Hong Kong).
Participants: 142 GPs and respiratory physicians
were chosen to include urban and rural GPs as well as
hospital-based and out patient-clinic respiratory
physicians.
Results: Management of acute COPD exacerbations is
dealt with within a scope of concerns. These concerns
range from ‘dealing with comorbidity’ through ‘having
difficult patients’ to ‘confronting a hopeless disease’.
The first concern displays medical uncertainty
regarding diagnosis, medication and hospitalisation.
These clinical processes become blurred by
comorbidity and the social context of the patient. The
second concern shows how patients receive the label
‘difficult’ exactly because they need complex attention,
but even more because they are time consuming, do
not take responsibility and are non-compliant. The third
concern relates to the emotional reactions by the
physicians when confronted with ‘a hopeless disease’
due to the fact that most of the patients do not
improve and the treatment slows down the process at
best. GPs and respiratory physicians balance these
concerns with medical knowledge and practical,
situational knowledge, trying to encompass the
complexity of a medical condition.
Conclusions: Knowing the patient is essential when
dealing with comorbidities as well as with difficult
relations in the consultations on exacerbations. This
study suggests that it is crucial to improve the
collaboration between primary and secondary care, in
terms of, for example, shared consultations and
defined work tasks, which may enhance shared
knowledge of patients, medical decision-making and
improved management planning.
INTRODUCTION
It has been shown that many patients with
chronic obstructive pulmonary disease
(COPD) are diagnosed too late.1 Many
patients who present to the emergency room
with exacerbations have never been diag-
nosed with COPD.2 In addition, COPD is
often misdiagnosed as asthma, leading to
inappropriate treatment.3 4 With regard to
the management of COPD, much attention
has been paid to the importance and diffi-
culties of preventing and treating the exacer-
bations.5 According to GOLD 2013 the
management of COPD exacerbations was
included as a specific section on the com-
bined management of COPD.6 Exacerbations
lead to emergency and hospital care7 and
each exacerbation leaves a permanent decre-
ment of lung function.8 More patients need
an expensive secondary care and long-term
health status is hampered if management of
exacerbations in primary care is suboptimal.9
To find novel solutions for improving
COPD care, we need more research on
experiences, practice and management
approaches of the persons primarily involved
in everyday care of COPD, the healthcare
Strengths and limitations of this study
▪ The study brings forward shared concerns of
managing chronic obstructive pulmonary disease
(COPD) exacerbations at a cross-cultural level.
▪ Several local experiences exist but there is a lack
of a general body of knowledge on challenges
and solutions.
▪ Doing a cross-cultural study exhibits methodo-
logical limitations, eg how to take into account
differing health system contexts.
▪ Focus group discussions (FGDs) do not tell us
much about consultations as they are practiced
but much about how they are thought to be
practiced.
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professionals and patients. A considerable amount of
qualitative research on the needs and views of patients
with COPD already exists. It has been shown, for
example, that the uncertainty regarding the differenti-
ation between asthma and COPD also has an impact on
patients with COPD. In the early stages of COPD,
patients do not recognise their symptoms, such as
coughing, as the first stage of a severe disease.
Consequently, they do not find their symptoms severe
enough to warrant a physician’s visit.10 Patients with
COPD also often feel ashamed about their medical con-
dition. They feel it is self-inflicted (caused by smoking)
and the resulting shame is undoubtedly an obstacle in
seeking medical advice, especially when they continue
smoking.1 10 11 A previous research has shown that
breathlessness is one of the most problematic symptoms
of COPD.12 Good self-management with medication is
very important for them to regain control of their
breathlessness and lives11 12; however, exercise pro-
grammes are approached with caution because of the
breathlessness.12 Although patients report feeling confi-
dent about self-management of their medication, they
are not confident about their actions in an emergency
situation.11
Qualitative studies on healthcare professionals and
their experiences of COPD treatment or care concen-
trated mainly on ‘stop smoking’ management.13–16 We
have not found qualitative studies that investigated the
views of healthcare professionals on regular COPD care,
although a few studies focus on perceptions of
end-of-life care, specific use of spirometry and under-
diagnosis of COPD.17–19
There are large differences between countries in the
way the primary care of patients with COPD is orga-
nised, and therefore local studies may have a limited
generalisability. We wanted to know which experiences
and challenges were shared by clinicians who care for
patients with COPD. Therefore, we set out to investigate
the experiences and opinions of GPs and respiratory
physicians regarding COPD care in seven different coun-
tries (Norway, Russia, Germany, the Netherlands,
Poland, Wales and Hong Kong). This analysis would
lead to a clear understanding of the main concerns in
COPD care. To investigate this in enough detail, we
focused on the assessment and management of acute
exacerbations. Our aim was to explore how GPs and
respiratory physicians reason when managing patients
with COPD exacerbations in clinical encounters.
METHOD
Design
The overall aim calls for a qualitative approach that
encompasses a basic understanding of human interaction
and social processes, for example, Grounded Theory
(GT).20 GT is furthermore, in its sampling and analytic
approach, theory driven and strives for theory develop-
ment of emerging categories.21 We employed a GT
approach, which is mainly based on Charmaz’s construc-
tionist version, but we are also inspired by Corbin and
Strauss’ paradigmatic model of actions and interactions
to help us develop an axis of the analysis.22 23
We chose focus group discussions (FGDs) as our
data sampling method and designed a study of 3×7
FGDs.24 25 The study countries were selected from the
start due to earlier research collaboration on respiratory
diseases with networks (GRIN and GRACE): Wales, the
Netherlands, Poland, Russia, Germany and Norway. The
study originally was thought to be of only European, but
early in the process we got an opportunity to include
Hong Kong. Hong Kong was in the analysis primarily
used for comparative purposes, adding an extra dimen-
sion to the analysis of the European countries. Each
country performed three FGDs with new participants
each time: FGD 1 with only general practitioners, FGD 2
with only respiratory physicians and FGD 3 with a mix of
GPs and respiratory physicians. The first FGDs were
undertaken in March 2011 followed by FGDs 2 in
September/October 2011 and FGDs 3 in February/
March 2012. All researchers from each country who
were responsible for conducting the FGDs participated
in a 3-day workshop where they were taught the method-
ology of GT and FGD methods, theoretically and with
practical exercises. This was performed in order to
streamline the methods across countries and try to
secure the shared knowledge and practice of the meth-
odology, basic to making a cross-country analysis.
All countries used the same topic guide each time with
a selection of already formulated prompts. Before con-
ducting FGD 1 the first topic guide was developed by the
main author with input from collaborating countries. A
pilot interview was conducted in Tromsø in order to
adjust for formulations, phrases and questions. Between
FGDs 1 and 2 the topic guide was discussed and revised
among the same authors but also with input from
research leaders from the other countries—all met for a
1-day workshop to discuss the categories identified in a
preliminary analysis of FGD 1 and to decide on how to
sample data according to this, that is, whom to include in
FGD 2 and what to ask. Between FGDs 2 and 3 a major
revision of the topic guide was made, also after a prelim-
inary analysis and development of categories and con-
cepts, but this time input was made by email from most
countries apart from the researchers in Norway and the
Netherlands who met to discuss the revision. This last
topic guide focused especially on providing knowledge
on topics that were still unclear but also on solutions to
identified challenges and difficulties on collaboration.
The two first topic guides included three patients’ cases
(see online supplementary files) to prompt the discus-
sion on the first three topics. These were not a part of
FGD 3 but instead the topics and the results from FGDs 1
and 2 were elaborated into new questions.
The interview guides contained the listed topics,
based on the known issues of concern to GPs. The
respiratory physicians were asked to discuss the routines
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in general practice as it was known to them, but inviting
them to be open about their own views and concerns.
The topic of collaboration was mainly brought into FGD
2 to try to meet a mutual concern, and the discussion
resulted in change of the third FGD’s interview guide:
FGD 1: assessment and medication/hospitalisation/
self-treatment/use of guidelines/challenging or difficult
situations/most important problem/improvement of
clinical practice.
FGD 2: assessment and medication/hospitalisation/
self-treatment/use of guidelines/challenging or difficult
situations/most important problem/improvement of
clinical practice/collaboration with GPs (the topics in
FGD2 were supplemented with more specific subques-
tions than in FGD 1).
FGD 3: diagnosis of exacerbation/hospitalisation of
borderline cases/criteria for self-treatment/collabor-
ation between primary and secondary sector/who are
the difficult patients (the topics of FGD 3 were supple-
mented with subquestions aiming at describing bottle-
necks and future solutions for each topic).
Sampling and material
All 21 FGDs were performed with a moderator and an
assistant moderator, except for a few where only a mod-
erator was present. The moderators were the head
researchers from each country network (a professor or
doctor in family medicine), and in one case a PhD
student and an epidemiologist. They were all closely
supervised. The head researchers had their main
research field in respiratory diseases in general practice
and the epidemiologist had a long experience with inter-
vention research in general practice while the PhD
student was new to the research field. Comoderators
were either skilled qualitative researchers or GPs with
research experience. The aim was to include 6–8 partici-
pants for each FGD.
Participants for FGD 1 were GPs and were sampled
purposefully to cover rural and urban practices. They
were invited via an information letter. Several informa-
tion channels were used in some countries, making con-
tacts via meetings, health boards, email, telephone, mail
or personal contact. By the end we had between 6 and
10 participants in each FGD and these lasted between 1
and 2 h. Several GPs did not wish to participate due to
limitation in time and interest.
Participants for FGD 2 were sampled among hospital-
based respiratory physicians and private or out-patient
respiratory physicians, depending on the specific health
system in each country. The number of participants
varied between 4 and 7 and the FGD lasted around
1.5 h. The participants were found via email invitations,
personal contacts or at hospital wards (eg, having a
respiratory physician ask colleagues) and sampling was
faster and easier than in FGD 1 but also resulted in
fewer participants.
Participants for FGD 3 were sampled among GPs and
respiratory physicians to enhance a discussion on the
emerging analytic categories in the data. FGD 3 had
between 6 and 9 participants and lasted from 1.5 to 2 h.
The sampling took place via e-mail invitations, through
personal contact or inviting a key person to ask collea-
gues. The composition of the FGDs had a balanced
number of GPs and respiratory physicians.
In some cases, the GPs came from the same practice
and knew each other. Also, respiratory physicians were
acquainted with each other, working at the same hos-
pital or out-patient clinic. In some FGDs the moderators
knew a few of the participants but this was not a domin-
ant tendency. The participants were not sampled accord-
ing to gender or seniority but we intended to include
physicians working in rural and urban settings as well as
at different types of health workplaces, mainly regarding
the respiratory physicians as aforementioned. The ones
who were included and informed us about their practice
time, about half of the participants, showed a long
average seniority (approximately 14 years) with the
respiratory physicians having the most seniority. GPs
practiced in single clinics, shared clinics and group prac-
tices as well as in health centers, and respiratory physi-
cians practiced at hospitals (regional as well as university
hospitals), outpatient clinics and in several cases at both
places.
All FGDs were performed within the university prem-
ises and they were transcribed verbatim from audio
recording by the local researchers and translated into
English by a skilled translator.
Analysis
The analysis took place according to GT methodology
from the first round of FGDs, using Nvivo V. 9. First and
third authors did the main coding, that is, line-by-line
coding in the beginning but we also coded by event,
constantly looking for meaningful categories and con-
cepts in the data and making comparisons across all
FGDs. The first-round analysis of FGD 1 was performed
by the Tromsø team mainly and its purpose was to guide
us and decide which categories and concepts should be
elaborated or perhaps de-emphasised in the following
FGD. The same process took place between FGDs 2
and 3. This whole approach aimed for a process of the-
oretical sampling. Furthermore, the analysis also con-
tained attempts to conduct focused coding23 in order to
find the most significant categories, concepts and
actions of the material, and this was again extended with
a preliminary axial coding trying to structure a relation
between categories and subcategories.22 The axial
coding was elaborated further in the final analysis, and
this was supplemented with a paradigmatic matrix that
organises data into conditions/actions and interactions/
consequences and helps to develop categories and find
relations between them.22 This paradigm also highlights
the actions and interactions of actors involved and helps
to define the core categories of actions/social processes
with their related dimensions, which finally are devel-
oped into a grounded theory. A special emphasis is put
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here on intentions and goals of the actors in the
process. Memos were written especially in the last phase
of the analysis, giving a solid basis to start comprehend-
ing the main concerns for the health professionals con-
cerning COPD exacerbations and how they handled
them. The analysis made by the Tromsø team was sup-
plemented and discussed with input from the study
countries’ teams. This created collaboration in terms of
the analysis and strengthened the validity of the find-
ings. The analytic findings are presented below in a
structure which first delivers the interpretation of find-
ings and subfindings, second illustrates these with quota-
tions and third, in some cases, elaborates or summarises
the interpretation based on inferences from the quota-
tions and on the overall analytic perspective.
RESULTS
Balancing management within a scope of concerns
Overall, data displayed several distinct discussions on
how to manage COPD exacerbations. Some FGDs were
very focused on problematic issues from the beginning,
others seemed more straightforward and practical, not
paying much attention to any difficulties, while others
again from the beginning tuned in on uncertainty con-
cerning medical practice and knowledge, prone to
discuss uncertainties and doubts. Some, after prompting
by a patient history, were dominated by a demonstration
of medical knowledge at the start. However, all FGDs
combined their medical concerns and discussions with
attempts to describe and understand the patient’s social
circumstances, as well as to take into account the par-
ticular health system and its resources as determining
factors in the management of exacerbations. When it
came to discussions on main challenges, clinical practice
and collaboration, several societal problems and political
dimensions of health work were addressed, for example,
with a tendency to shift the level of attention from bio-
medicine to health promotion, health services topics
and general health population issues.
The analysis of all FGDs made it evident that the man-
agement of COPD, especially of exacerbations, is experi-
enced as trying to balance between medical knowledge
and practical, situational knowledge. Balancing manage-
ment per se is the main concern for GPs and respiratory
physicians, resolved mainly by strategies of knowing
patients, their social resources and health contexts.
However, this concern only makes sense when subcat-
egories of concerns are explained and analysed one by
one, showing the mechanisms of an interconnected
process, that is, a scope of concerns.
Dealing with comorbidity
‘Dealing with comorbidity’ is a concern which is signifi-
cant for three different dimensions of clinical manage-
ment of exacerbations: how to be sure it is an
exacerbation, when to prescribe antibiotics or steroids
and when or whom to hospitalise. Comorbidity refers
here to the existence of disease conditions other than
COPD, such as asthma, cardiovascular disease, skeletal
muscle dysfunction, metabolic syndrome, osteoporosis,
depression and lung cancer.
Crucial to a diagnosis of exacerbation, we found in
the FGDs that all the physicians wished to see the
patient when he/she calls the GP and asks for antibiotics
because of a worsened condition. To merely give advice
or to prescribe over the phone could be suitable for
some, but only if they knew the patient well. As such,
making a diagnosis of COPD exacerbations was closely
connected to seeing, knowing and examining a patient.
However, just as important, symptoms like breathlessness
and anxiety were understood to be caused by multiple
possible diagnoses, that is, the questions of comorbidity
blurred the picture. Not everything resembling an
exacerbation is one:
It is difficult, for example, to diagnose COPD in an
80-year old patient. I had such a patient. The doctor
[GP] diagnosed her with asthma. This is a non-smoking
patient. Her FEV1 is 27%. I have a question: what is it? Is
it COPD or asthma? The test with bronchodilator was
positive. Such mixed cases are difficult. Although today
we treat such cases in the same way, with combined medi-
cines. In general, we have a lot of difficulties in diagnos-
ing the severe patients. (Russia FGD 2)
In terms of theoretical medical knowledge, making a
diagnosis could be presented by the physicians as
straight forward, but the clinical picture of comorbidity
confused the process:
Yes, but still, it [making a diagnosis] is not difficult at all.
It’s the matter of, it’s the many comorbidities among
them, everyone at risk for COPD is rather at risk of, well,
cancer and cardiac diseases are quite common among
COPD patients. (Norway FGD 3)
Diagnosing was perceived overall to be a clinical
process made over time, using in particular the patient’s
history and experiences to estimate an exacerbation,
trying to judge if the patient does have an exacerbation
or not.
Comorbidity was also described as a crucial factor when
deciding whether or not to prescribe antibiotics and ster-
oids, and this made prescribing decisions difficult:
these patients have often got a load of other things
wrong with them, they are high risk individuals, they have
been smoking for many years and I think the main worry
is about, is the things that we talked about, is multiple
pathologies, multiple drugs. (Wales FGD 1)
Concerning the steroids, the respiratory physicians in
FGD 2 seemed to be, overall, in favour of prescribing ster-
oids for an exacerbation for a limited time period and
discussed more intensely whether to give antibiotics and
on what basis, due to resistance considerations.
Conversely, for the GPs it was ‘easier’ to prescribe
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antibiotics, but giving both drugs at the same time was
not their first option, especially when considering
comorbidity. The side effects of long-term use of steroids
and the risk of inducing pneumonia were decisive issues
for the GPs:
Usually, we should be concerned whether there is an
infective component when we prescribe steroids. Usually
chronic COPD patients are weak and if we prescribe
steroid for them, it will be easy for them to get infection
and often I will prescribe antibiotics as daily practice.
(Hong Kong FGD 1)
The comorbidity is high and I reckon that every COPD
patient has some form of presence of one or more disor-
ders in addition to a primary disease or disorder…[…]…
When visiting the practice I will often put them on a
scale. They need to be weighed anyway for COPD. So if
they have gained 4 kg I am not sure to send them home
with a dosage of prednisone and say they’ll be fine. (The
Netherlands FGD 1)
When considering whether or not to hospitalise, this
was illustrated in long debates on pros and cons. The
possibility of comorbidities such as heart failure, dia-
betes, pneumonia, anxiety or psychosomatic disorder
was an important consideration for the physicians. A sus-
picion that a patient had an undiagnosed comorbidity
might be reason enough to admit a patient.
E: I think it also depends on the severity of the disease
before the exacerbation, that is, how much strength the
patient has got left. If he is unstable anyway, even if he
isn’t exacerbated, then that’s a reason to hospitalize him
of course. The other possibility would of course be, that
you have been treating him with different therapies and
you say, I don’t see any significant changes, and this has
to be analysed in more detail.
G: And it also depends on the comorbidities, what other
diseases he has. (Germany FGD 3)
For COPD exacerbations in general objective assess-
ments, such as low oxygen saturation and rapid respira-
tory rate, were the most obvious criteria for
hospitalisation:
I think there are two important things with this case,
firstly how well the GP knows the patient so he can
compare them to their baseline and secondly an object-
ive assessment, oxygen saturations, respiratory rate, heart
rate, all these sort of things, a clinical consultation, I
think. (Wales FGD 2)
On the other hand, after taking into account the
patient’s basic medical status, how well the patient is
known and his general condition, decisions about hospi-
talisation came down to whether one would risk letting
the patient stay at home despite comorbidities or social
situation, or wishes:
[I will assess]…age, comorbidity, the increase of respira-
tory failure, whether a patient can sleep or he is sitting
all night in this position, orthopnea as he can... what
kind of work around the house, he can perform. Can he
dress himself, can he move around the apartment, or
does it gives him a hard... can I manage treatment... And
if relatives can help in treating him at home... (Russia
FGD 1)
On the other hand you also have to see, how multimor-
bid the patients are. Cardiac decompensation, exacer-
bated COPD, back and forth again and again, sure it’s
difficult, but you have to ask yourself “how far can I treat
this locally? What can I achieve?” So that we have, right,
we all also are in the ambulatory area, we also have our
limits. And if we have such complicated cases, where
there is something wrong again and again, and we have
to ask us diagnostically “What is the real problem?”, there
I sometimes believe, that some patients, also if they are
tired of it, would be better off at a hospital. (Germany
FGD 3)
Yes, and so social factors also play a role, if she lives alone
and doesn’t have any security network at home you can,
at any rate, be more unsafe when deciding to send her
home, and I assume that one would tell her, in case you
don’t admit her… you would have a lower threshold to
do so if she gets worse. (Norway FGD 2)
The elements of medical decision-making, that is
assessment, tests, diagnosis, medication, hospitalisation
and overall management, were on one hand discussed
within the framework of highly complex medical
matters, weighing biomedical, pharmaceutical and
technological knowledge against each other, and on the
other hand taking into account knowledge of the social
context of the patient. Indeed, the patient’s social condi-
tion, background, resources and personal profile were
highly important for all concerns of ‘dealing with
comorbidity’ and clinical decision-making in order to
balance medical knowledge:
There are so many things that you have got to take into
account like social circumstances, does he have someone
in the house to keep an eye on him, do they have a
whole load of other co-existing illnesses, um you know
it’s very difficult to pick on one thing, it’s you trying to
make a decision on a number of factors. (Wales FGD 1)
Participants’ thoughts about the use of medication
indicated a specific concern for the patient and a wish
to know more to support a medical decision. These
thoughts were medically informed and patient-centred,
for example, how high doses were acceptable and for
how long, when was it rational to prescribe antibiotics or
steroids according to clinical findings and history, how
would the patient accept medication, would he be com-
pliant (concerning up-take and purchase of medicine)
and would he be able to have a dialogue on effects and
use with his physician:
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Now we talk a lot, but if you know him, then you know
whether he already had something like this in the past.
Do you have the case history, does he have compliance?
Does he take his medication? Or not? Or is he someone
who comes along, I don’t know, and maybe had an infec-
tion as a trigger, he still smokes heavily and now found
his spray and has been using it for 2 days and it doesn’t
help yet. (Germany FGD 1)
Thus, knowing the patient in several ways and at
several levels was a common approach, and this situ-
ational knowledge was used for gaining a complemen-
tary understanding of how to treat the patient and
determine the necessary medical steps to take.
Having difficult patients
The second concern emerging from the FGDs is ‘having
difficult patients’. This concern contains a shift in per-
spective moving from seeing ‘comorbidity’ as a problem
to how the GPs and respiratory physicians may see the
patient and the relationship with the patient as a
problem. In this move, the patient as a person and his/
her personality, situation and context are in the fore-
ground, not the medical condition per se.
A common dimension of ‘the difficult patient’ is pre-
sented in some of the first reactions from the GPs and
respiratory physicians when they start talking about
patients with COPD. On one hand, it is a relief that the
management and treatment of these patients in general
has become easier and more successful due to new
drugs (although treatment may still be complicated
because of complex conditions), but, on the other
hand, some physicians feel annoyance when they per-
ceive that patients have unrealistic expectations:
In general, these patients are more difficult; the patients,
who have a lot of expectations, and believe that all of
their ‘affairs’ will be resolved for them (by someone
else). I don’t particularly like those patients; they are dif-
ficult to cooperate with, perhaps, just because of their
belief that everything should be done for them. (Poland
FGD 1)
More often though, having patients with COPD
exacerbations generates mixed feelings of concern for
the patient. The patients are difficult exactly because
they are seriously ill and suffer and need complex atten-
tion, while at the same time they are difficult because
they are time-consuming, frequent attenders, non-
compliant and often do not give the physician the satis-
faction of being helpful:
As for me COPD patients are men with long smoking
experience, they are often poor, of low social status,
alcohol dependent, they usually don’t follow the pre-
scribed treatment. They simply don’t have enough
money for treatment. I examine them and usually refer
to the hospital or to the expert bureau. Generally it is a
very sad story, usually leading to disability. There are very
few effectively treated patients. (Russia FGD 3)
Especially, when discussing self-treatment, the patient
and his/her social profile turn up as a problem—prob-
ably because here the patient is delegated an active role,
and behaviour and context becomes even more decisive
for a decision to prescribe self-medication. Being a ‘diffi-
cult patient’ is further dependent on a spectrum of diffi-
culties pertaining to the patient himself, such as poor
illness perception and understanding (resulting in
undertreatment or overtreatment), smoking habits/life-
style/behaviour, poor intelligence, poor compliance, old
age and bad quality of life/poor economy. But the label
of being difficult also results from unsuccessful/lack of
interaction and communication with the health profes-
sionals to improve one’s situation together.
There are a couple of things we encounter such as most
patients are ‘dead horses’. This does not sound respectful
but there are a lot of patients who want to be left alone.
We cannot make them understand what we expect from
them. Be active, quit smoking, more exercise, loyal to
therapy, take their own initiatives. (The Netherlands
FGD 2)
We refer them to this school while they are on a sick
leave. We try to convince them of something, especially
of the necessity to refuse smoking. It seems that they
agree, nod, everything is understood, but they don’t
come to the second or third meeting. We don’t see the
light in their eyes; we don’t see their initiatives, their par-
ticipations, any support for their care. Therefore, we have
refused to conduct school for COPD patients as we don’t
see the interest from the patients. (Russia FGD 2)
In other words, a patient was seen as ‘difficult’ as a
result of an interaction, or ‘difficult’ was an already
made characteristic clinging to certain disease profiles,
either due to earlier experience with a patient or due to
generalised knowledge of patients with COPD.
Moreover, the difficult patient is a typology referring to
the continuum of concerns and not all patients are
labelled as such. Some, indeed, are mainly difficult
because they have difficult illness conditions. But still,
the physicians’ perceptions of having ‘difficult’ patients
in terms of social and personality-related difficulties, not
explicitly related to the medical condition, govern
several interactions. The physicians try out several prac-
tical solutions to this and one important overall action
suggested is to get better at motivating the patients.
Motivation is the key to several aspects of the difficulties
they meet in patients. A repeated advice here is to teach,
instruct and inform patients—about the disease, about
medicine and especially about the right self-treatment.
To teach and motivate is the main action pertaining to
‘the difficult patient’—but it builds on the necessity to
know and involve the patient in a relationship in order
to address him/her properly:
I think that is what GPs are supposed to do. I think that
most GPs, especially the younger ones, think highly of
communication. It matches well. It is difficult and the
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relationship between yourself and the patient is very
important. Getting people to quit smoking. The times
that you succeed are very rewarding. People are genu-
inely happier/healthier when they have quit smoking.
And the whole story of empowerment as they call it, that
you trust the patient to be able to handle his/her own
problems. I think that patients are rather dependent.
(The Netherlands FGD 1)
Confronting a hopeless disease
The third concern in the scope of management deals
with how to balance one’s approach to a disease that
confronts the physician with his medical professional
limits, that is, the limits for curing and saving lives, and
with the patient’s existential deterioration at all stages—
suffering in general and at end-of-life stages. In this
approach, it is primarily the disease in itself which the
physicians react emotionally upon. It is the disease that
makes the encounter with the patient becomes charac-
terised by shifting feelings of empathy, hopelessness or
frustration, notably related to COPD in general more
than to only exacerbations. The severity and poor prog-
nosis of the disease per se gave, for example, either an
atmosphere of frustration or simply created a pragmatic
attitude:
They are the most severe patients among the patients
with broncho-pulmonary pathology. This is the category
of severe patients, which you don’t know how to help, in
spite of all the standards what exist today. Dyspnea will
come anyway. Neither oxygen, nor steroid therapy,
neither bronchodilators, nor courses of antibiotics—
sometimes nothing for these patients can be done if a
patient has severe COPD. (Russia FGD 2)
Another difficult matter is that they don’t get better at
all…[…]… it’s like you prescribe one drug after the
other but their conditions worsens gradually and they
suffer from difficulties in breathing and in the end we
have nothing left to help them with. (Norway FGD 1)
Other reactions seen were expressions of sympathy
and feeling sorry for the patient in the light of a quickly
deteriorating chronic disease:
And you also have these fatal developments, we know
that about COPD, you can use the maximum therapy
and the patients do as they are told, but still it gets worse
bit by bit. And that’s especially dire. That’s where you
really pity them, because you are so powerless. That’s
how it is then. (Germany FGD 3)
Another often mentioned dimension of this concern
dealt with smoking. Smoking habits and the failure of
smoking cessation were considered as the main obstacles
for the prevention of exacerbations and the discussions
on this topic were often marked by hopelessness con-
cerning the patient’s capabilities of cessation.
We give patients with mild or moderate stages of COPD
anticholinergics, explain them why they need such
treatment. And they do not give up smoking. Sometimes
I have the opportunity for a whole hour to talk with the
patient. [We] spend a lot of energy and the energy
without any feedback. Dim eyes. [They] like smoking,
and continue smoking, although they agreed to stop. But
he doesn’t do anything. (Russia FGD 2)
Continuous smoking habits became unintelligible to
the physician and his attempts to ease symptoms and
relieve a condition, especially when a patient experi-
enced acute exacerbation. Patient’s smoking habits in
general were an especially dominant concern for the
physicians, not merely as a simple lifestyle issue. They
invoked strong emotional reactions among the physi-
cians when faced with suffering, deterioration and death
due to smoking. In the light of this, many discussions on
smoking cessation may be seen as attempts to strategic-
ally manage a critical disease and an experience of
being professionally helpless and emotionally touched.
Also non-compliance of medication was a source of dis-
content and puzzlement among the physicians. Such
experiences often created an air of hopelessness and
helplessness which were related to the concern of
‘having difficult patients’. But here we wish to emphasise
that the feelings of the physicians were triggered by the
disease more than by the interaction with the patient.
The feeling of hopelessness was experienced also in
relation to systemic factors; for example, if oxygen was
not available or hospital care was inadequate. Despite all
these negative experiences, an overall preoccupation
with the patient was always present, resulting in actions
of care even for the patient with ‘the hopeless disease’.
For those who might still increase their quality of life,
discussions on the value of rehabilitation and especially
physical exercise came up as an answer and as possible
strategies to prevent deterioration into stage III or IV
COPD. Rehabilitation was especially brought up as an
overall concern for the patients’ social life, involving
several suggestions of practical advice and how to teach
patients and their families, for example, basic disease
management, physical exercise and smoking cessation,
organised in COPD schools. However, rehabilitation
attempts were hampered by a lack of programmes,
access, financial priority and collaboration, especially in
Russia and Poland.
It is not being founded. Anyway, there is no tradition of
rehabilitation in diseases of the respiratory tract in
Poland. (Poland FGD 2)
...no one said anything about the rehabilitation of
patients... here it is, I think quite an important point...
and, by and large, we do not know how to perform
[rehabilitation]. (Russia FGD 1)
… the evidence is very clear, that a rehabilitation
program on COPD-exacerbation is something extremely
good. The evidence is OVERWHELMING and the health
insurance companies nearly NEVER cover the costs for it.
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And that’s something that can drive you mad. That the
evidence is crystal clear, but the attitude of the insurance
is also crystal clear: We won’t finance rehabilitation pro-
grams. And that is a daily conflict that we have to fight.
(Germany FGD 2)
But, but that is the solution, the solution is not to send
patients to an extremely expensive rehab center, the solu-
tion is gathering people, making people aware, and I am
convinced if you buy a set of Nordic walking equipment
and you find two buddies to walk with, you have both the
element of resocialising and a healthy exercise com-
bined, people are given perspectives again, for 30 euros
you can set up an exercise program. Thirty euros for
Nordic walking equipment, when buying at Aldi it is even
cheaper. But what you need is to make the patients aware
of it, and when they do not concretize and you will treat
them with drugs it will be ineffective. The challenge and
art is to motivate the patient, and subsequently imbed
Nordic walking equipment. (Netherland FGD 2)
Palliation for patients with COPD came up as a topic
of discussion in many FGDs. This was phrased as a worry
that the patients would not receive the optimal palliative
attention, for example, compared with patients with
cancer, or that the physicians did not attend enough to
provide palliative care:
…[…]…not going to make them better, so a lot of them
will just slowly progress and they’ll get worse and worse
and worse and then eventually what we should be doing
is referring a lot of them to [palliative care], they
shouldn’t be down the chest side of things and so, pallia-
tive care deals with cancer that’s fine, you know, but they
don’t deal with conditions that aren’t cancer, no, no they
do, they do but what I’m saying is that now we should be
using that a lot more. (Wales FGD 2)
DISCUSSION
The management of acute COPD exacerbations was
dealt with within a scope of concerns. These concerns
ranged from ‘dealing with comorbidity’ through ‘having
difficult patients’ to ‘confronting a hopeless disease’.
The first concern relates to medical uncertainty regard-
ing diagnosis, medication and hospitalisation. Here, the
clinical process was often presented as straight forward
in terms of theoretical medical knowledge, but became
blurred by issues of comorbidity and social context. The
second concern is when ‘difficult’ becomes an attribute
of a patient. Patients were difficult exactly because they
needed complex attention, but even more because of
personality aspects triggered annoyance, they presented
poor illness understanding, and were time consuming,
did not take responsibility and were non-compliant. The
third concern relates to the emotional reactions by the
physicians when confronted with ‘a hopeless disease’
due to the fact that the disease is chronic and progres-
sive and the treatment options slow down the process at
best. Physicians met their own limitations and reacted to
end-of-life stages of COPD and patient’s poor quality of
life. GPs and respiratory physicians balance the concerns
of ‘dealing with comorbidity’, ‘having difficult patients’
and ‘confronting a hopeless disease’ with medical knowl-
edge and practical situational knowledge, trying to
encompass the complexity of a medical condition. They
engage vividly in suggestions to improve future consulta-
tions and patient lives, making an effort to create effect-
ive medical routines (see figure 1).
Comorbidity and the social context of the patient
complicated the management of disease. In everyday
practice the complicated rather than the straight-forward
patient profile is probably most common, considering
the high prevalence of comorbidity in this patient
group.26 This also illustrates that physicians feel the lack
of good guidelines incorporating comorbidity issues
clearly.27 Therefore, an important aim for future COPD
guidelines would be to describe management options
within the context of the most prevalent comorbidities
in COPD. In addition, there is a need for more prag-
matic trials in patients with COPD that do not exclude
elderly patients or patients with comorbidity. Increased
collaboration between general practice and hospitals was
also suggested as an approach in dealing with uncertain-
ties around comorbidities. Collaboration could lead to
standardisation of assessment, establishment of joint
consultations in order to make pulmonology services
more available to GPs, definition of work tasks specific
for each specialty and more involvement of GPs in hospi-
talisation decisions and discharge.
Patients with COPD who experience exacerbations are
commonly viewed as difficult patients, with some physi-
cians even saying that they do not particularly like these
patients. Little is known about this emotion among phy-
sicians, but this finding is in agreement with qualitative
studies among patients with COPD where they express
the feeling that they are blamed for their self-inflicted
disease, not only by their own social environment, but
also by healthcare workers.28–30 The management of
COPD exacerbations and stopping smoking require an
active role of the patient, so it is understandable that
healthcare professionals may feel frustration if their
advice is not followed. On the other hand, the resulting
emotional impact of blaming patients is likely to have a
negative effect on the patient’s mood, which will further
hamper the relationship and the clinical process.30 The
‘difficult’ patient is well known from studies on other
kinds of patients and is commonly attributed by physi-
cians to mental disorders, personality traits or morally
flawed behaviour.31 Fiester, however, argues, that the
label ‘difficult’ is best explained by problematic interac-
tions or reactions to the delivery of care, and he also
notes, similar to what we found, that a physician may
label a patient ‘difficult’ or ‘hopeless’ because of her or
his own inability to effectively diagnose or treat the
problem or because of a patient’s reaction to this
failure. He points to the problem as an ethical one
requiring an ethical consultation service. In our study, to
overcome ‘difficult’, the physicians focus on improving
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instructions to patients and to target the instructions
according to their capacities—that is, mainly an
approach to optimise knowledge. The GPs may need
supportive actions for this from the health system and
society. Concerning self-treatment, concrete future steps
were identified in the data such as using management
plans including ‘rescue packs’, having a nurse to take
specific care of self-treatment and arranging teaching
sessions involving the patient’s spouse and family, as has
shown to be effective in, for example, Bourbeau et al.32
However, as suggested by Abbot, the most fruitful
approach might be to deal with ‘the difficult interaction’
rather than targeting either the patient or the phys-
ician.33 Therefore, programmes that specifically focus on
improving the physician–patient relationship might be
worth investigating.
Our finding that physicians feel powerless and fru-
strated because they have nothing really to offer the
patient has been reported in other qualitative studies,34
but detailed literature on this subject is very limited.
Physicians feel that they do their best, approach the
patient with care and try to work according to the guide-
lines, but that there is little progress and only deterior-
ation in the condition of the patient. Practical future
steps include prioritising pulmonary rehabilitation,
including adequate resourcing and ensuring that it is
accessible for those in need, as well as a specific focus
on physical exercise and physiotherapy. Also, a more
concurrent focus on palliative needs and care and the
ability to refer these patients to palliative teams were war-
ranted. Pinnock et al35 suggest that an assessment should
take place related to hospital admission for exacerba-
tions. A patient study determining palliative needs found
considerable needs in relation to breathlessness but
fewer in the end-of-life stage.36 This is elaborated in
Habraken et al37 who point to the silence of patients
with COPD about end-stage needs because they do not
realise there are possibilities to improve their condition.
This, together with our study of the physicians, suggests
potentials for improvement of palliative care.
Overall, the physicians in this study refer in many dif-
ferent ways to the significance of knowing the patient—
and different dimensions of knowing him/her. We find
that knowing concerns the disease and comorbidity and
it addresses several practical issues of treatment: for
example, a patient’s difficulties using an inhaler, the
support available from family and relatives, a patient’s
capacity to learn about colour codes for medicine or his
ability to access a rehabilitation centre. In other words,
knowing the patient also means that a GP does not or
cannot always rest on clear evidence-based medicine, but
that he, together with the patient, may deal with chan-
ging and context-dependent patient needs. We see this
knowing in our data, where it shows that patient and
physician together try to adapt to the best treatment and
take into account situational contexts and practical and
social circumstances. This approach is related to a
concept promoted by Mol, ‘the logic of care’, which
embraces the patient and the doctor as active parts who
together create an adequate treatment.38 Knowing also is
an approach that is central to the suggested collabora-
tions between health professionals/health sectors and
which is sought to be enhanced through collaboration.
The overall strength of this study is to be found in the
design. It was designed as a cross-country study in order
to attempt to find common crucial concerns within
COPD exacerbation management in different health set-
tings. There is a general lack of such comparative studies
and our findings are grounded effectively in the whole
empirical material. On the other hand, the focus on
common issues may overshadow local contexts and local
details on management. Also, there is always a danger
that a comparative aim looks more for commonalities
and convergences than for divergences. However, during
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the analysis we made an effort to scrutinise any major
deviances to determine whether they had significance
for the development of new analytical concepts or
whether they were dimensions or properties to already
found categories. Other variations are a part of the
detailed examples of the illustrated concerns. Hong
Kong was chosen to compare European management to
a supposedly different kind of management, but the
data from Hong Kong turned out to support and
comply with the analysis of the other countries. A weak-
ness in the study and this analysis is that we were not
able to specify exactly what role the different health con-
texts played for the construction of the concerns. That
is, we were aware that discussions in the FGDs were
embedded in local health systems. They played a part in
how physicians talked about their own medical practice,
how their practices were framed economically and how
working conditions were experienced and practically
operationalised. Furthermore, GPs and respiratory physi-
cians might not necessarily share the same medical
knowledge background. However, a large part of the par-
ticipants had changed career from, for example, GP to
internal medicine, or working in hospital service for
several years before becoming a GP. Also many worked
in outpatient-policlinics (GPs and respiratory physicians)
or outpatient-clinics combined with either hospital
wards or health centres (GPs). This, we believe, lumps
the two specialties together rather than splitting them
concerning the medical experience. Hence, regarding
the concerns we found in the analysis, it still seems justi-
fied to talk about shared concerns. But certainly, we fully
acknowledge that there are differences within the con-
cerns that are both culture-specific, health system-
specific and determined by different social and medical
practices. We argue that the concerns are alike, but how
to administer them in detail, how the specific perception
was of patients, how collaboration could be improved,
etc, varied from country to country. Future analyses of
the dataset will draw in more focus on, for example, dif-
ferences among the countries in self-treatment and the
role of health systems. Methodologically, the fact that
the FGDs were performed by different moderators did
result in variations of moderation style and subsequent
heterogeneity in FGDs. All were trained to perform alike
with the same questioning route to follow but focus
groups develop independently, often as a result of the
participants. That the participants sometimes knew each
other may have created a barrier for critical discussions,
especially if seniors and juniors were together. It did,
however, also in some cases, give a more safe setting for
in-depth discussions. The moderators’ background in
general practice and interest in respiratory diseases may,
on one hand, have been an advantage because the
topics of the FGDs were well known. But, on the other
hand, it might have created a blind eye towards specific
areas. We saw that the PhD student and the epidemiolo-
gist more than others asked into themes just to under-
stand what was meant. Also their background in
different nationalities and medical discourses may have
coloured the interviews, but this counts for the partici-
pants as well. Most importantly, all major topics were dis-
cussed in all FGDs and the methodological conditions
above did not, in our view, jeopardise the present ana-
lysis. Concerning the translation there is always a risk
that phrases and concepts have lost their significance
during translation—certain translations were, however,
discussed with the responsible researcher when the first
author became in doubt about its content. Another limi-
tation is that the interviews and the study overall were
intended to focus on exacerbations, and while the
patient history and the medical discussions did so, it
proved inevitable for the physicians to leave out the
thoughts and reflections on the patients with COPD and
the COPD disease in general in many other aspects of
the interviews. This is especially reflected in thoughts
related to the third concern. We were aware of this
during analysis and decided not to try splitting the
results artificially into what dealt with exacerbations and
what did not. Finally, sampling of the participants was
intended to be strategic but turned out to be more prag-
matic due to recruitment difficulties and due to differ-
ences in health systems.
Unanswered questions and future research derived
from our study point to the need for more observational
studies on how management in real life takes place.
Studies addressing the benefits of management plans
and understanding the low status of patients with COPD
among GPs would also be of benefit.
CONCLUSION
Knowing the patient is essential in dealing with
comorbidities as well as with difficult relations in the con-
sultations on exacerbations. This study suggests that it is
crucial to improve collaboration between primary and
secondary care, in terms of, for example, shared consulta-
tions and defined work tasks, which may enhance shared
knowledge of patients, medical decision-making and
improved management planning. It also suggests that the
GPs need supportive actions from the healthcare system
and the society to target difficult consultations. Further
studies are needed on barriers in the doctor–patient col-
laboration and how to reduce the GPs frustration with
patients with COPD, in order to promote an optimistic
and fruitful attitude to this group of patients.
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